Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Anthelminthic Agents

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...

Leishmaniasis

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...

Malaria

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...

American Trypanosomiasis

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...

Giardiasis

Giardiasis

Giardiasis is a globally prevalent intestinal infection caused by the protozoan parasite Giardia duodenalis (also known as G. lamblia or G. intestinalis). This flagellated protozoan is the most frequently identified intestinal parasite in the United States and worldwide. Transmission primarily occurs via the fecal-oral route, with infection arising from ingestion of water or food contaminated with cysts. Individuals in low-resource settings, international travelers, outdoor enthusiasts, daycare...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Health care at the end of the road: opportunities from 20 years of partnership in onchocerciasis control.

Global public health·2009

Same author

Operational lessons from 20 years of the Mectizan Donation Program for the control of onchocerciasis.

Tropical medicine & international health : TM & IH·2008

Same author

A global initiative for the elimination of avoidable blindness.

Community eye health·2007

Same author

Towards the elimination of onchocerciasis.

Annals of tropical medicine and parasitology·2007

Same author

Eliminating onchocerciasis as a public health problem.

Tropical medicine & international health : TM & IH·2004

Same author

A simplified cataract grading system.

Ophthalmic epidemiology·2002

Same journal

Some observations upon the maintenance of Australorbis glabratus in the laboratory.

Annals of tropical medicine and parasitology·2014

Same journal

A new species of Phlebotomus (Diptera, Psychodidae) from Uganda.

Annals of tropical medicine and parasitology·2014

Same journal

The length of exposure to infestation and the danger of contracting onchocerciasis.

Annals of tropical medicine and parasitology·2014

Same journal

Observations on Chrysops silacea and C. dimidiata at Benin, Southern Nigeria. II.

Annals of tropical medicine and parasitology·2014

Same journal

Embryonated eggs of Ascaris lumbricoides in the wall of a human hernial sac.

Annals of tropical medicine and parasitology·2014

Same journal

Studies in the chemotherapy of cholera. VI. Protection by pteridines of mice infected with Vibrio cholerae.

Annals of tropical medicine and parasitology·2014

See all related articles

Search research articles

Related Experiment Video

Updated: Jul 2, 2026

Use of Micropipette-Guided Drug Administration as an Alternative Method to Oral Gavage in Rodent Models

Use of Micropipette-Guided Drug Administration as an Alternative Method to Oral Gavage in Rodent Models

Published on: July 26, 2024

The Mectizan Donation Program (MDP).

B Thylefors¹

¹Mectizan Donation Program, 325 Swanton Way, Decatur, GA 30030, USA. jlawrence@taskforce.org

Annals of Tropical Medicine and Parasitology

|September 26, 2008

Summary

This summary is machine-generated.

The Mectizan Donation Program has provided millions of treatments for onchocerciasis and lymphatic filariasis, improving public health. Future efforts focus on integrating treatments into primary healthcare and addressing challenges in endemic regions.

More Related Videos

Modification of the Treatment Methods for Wasting Marmoset Syndrome with Tranexamic Acid and Supportive Measures

Modification of the Treatment Methods for Wasting Marmoset Syndrome with Tranexamic Acid and Supportive Measures

Published on: July 12, 2024

Toxicological Assays for Testing Effects of an Epigenetic Drug on Development, Fecundity and Survivorship of Malaria Mosquitoes

Toxicological Assays for Testing Effects of an Epigenetic Drug on Development, Fecundity and Survivorship of Malaria Mosquitoes

Published on: January 16, 2015

Related Experiment Videos

Last Updated: Jul 2, 2026

Use of Micropipette-Guided Drug Administration as an Alternative Method to Oral Gavage in Rodent Models

Use of Micropipette-Guided Drug Administration as an Alternative Method to Oral Gavage in Rodent Models

Published on: July 26, 2024

Modification of the Treatment Methods for Wasting Marmoset Syndrome with Tranexamic Acid and Supportive Measures

Modification of the Treatment Methods for Wasting Marmoset Syndrome with Tranexamic Acid and Supportive Measures

Published on: July 12, 2024

Toxicological Assays for Testing Effects of an Epigenetic Drug on Development, Fecundity and Survivorship of Malaria Mosquitoes

Toxicological Assays for Testing Effects of an Epigenetic Drug on Development, Fecundity and Survivorship of Malaria Mosquitoes

Published on: January 16, 2015

Area of Science:

Tropical Medicine
Public Health
Parasitology

Background:

The Mectizan Donation Program (MDP), launched in 1987, has been pivotal in controlling onchocerciasis (river blindness).
Expansion of MDP in 1998 included treatment for lymphatic filariasis in co-endemic African countries.
Partnerships with non-governmental organizations and ministries of health have been crucial for program success.

Purpose of the Study:

To review the historical development and achievements of the Mectizan Donation Program.
To highlight key strategies and challenges in mass treatment programs for onchocerciasis and lymphatic filariasis.
To outline future directions for sustainable disease control initiatives.

Main Methods:

The study reviews the history and impact of the Mectizan Donation Program.
It highlights the development of community-directed treatment strategies.
It discusses drug management, safety research, and program expansion.

Main Results:

Over 69 million Mectizan treatments for onchocerciasis were provided in 2006, with projections to exceed 100 million annually by 2010.
Significant public health and socio-economic benefits have been realized in endemic populations.
National mass treatment programs are now established in all 33 endemic countries.

Conclusions:

The MDP has successfully expanded Mectizan distribution for onchocerciasis and lymphatic filariasis control.
Future sustainability requires integration with primary healthcare and addressing challenges in fragile states and loiasis-endemic areas.
Continued research and strategic planning are essential for long-term success and control of neglected tropical diseases.